Publications by authors named "M V Khvostov"

Article Synopsis
  • The research focuses on finding effective agents against coronaviruses, specifically by synthesizing thiazolo-thiophenes based on usnic acid to inhibit SARS-CoV-2's main protease.
  • Certain modifications of the thiophene groups showed moderate antiviral activity, while others had no effect, with kinetic parameters evaluated for the most promising compound.
  • The most active compound exhibited strong binding to the protease and effective antiviral activity against various SARS-CoV-2 strains, aligning molecular dynamics results with experimental findings.
View Article and Find Full Text PDF

Despite the long history of use and the knowledge of the genetics and biochemistry of , problems are still possible in obtaining a soluble form of recombinant proteins in this system. Although, soluble protein can be obtained both in the cytoplasm and in the periplasm of the bacterial cell. The latter is a priority strategy for obtaining soluble proteins.

View Article and Find Full Text PDF
Article Synopsis
  • Type 2 diabetes mellitus (T2DM) is a widespread chronic disease, and despite existing treatments, their side effects necessitate the search for new diabetes drugs.
  • This study tested two compounds, QS-528 and QS-619, on a diet-induced T2DM model in animals, finding that QS-619 effectively lowered blood sugar levels while QS-528 offered liver protection.
  • The research revealed that both compounds activate the free fatty acid receptor-1 (FFAR1), potentially working as full agonists and enhancing insulin and glucose-dependent hormones in mice.
View Article and Find Full Text PDF
Article Synopsis
  • FFAR1 agonists are being researched as potential treatments for type 2 diabetes due to their ability to lower blood sugar levels without causing hypoglycemia.
  • The study involved synthesizing seven new compounds as structural analogs, modifying a previously developed FFA1 receptor agonist to investigate their effects on blood sugar regulation.
  • The novel compounds demonstrated activation of FFAR1 and increased glucose uptake in liver cells without toxicity, with two specific compounds showing significant hypoglycemic effects in glucose tolerance tests on mice.
View Article and Find Full Text PDF